Table 1 Patient demographic and clinical information

Clinical data

Mean age (SD), y

63.91 (6.45)

Median PSA (IQR), ng/ml

6.92 (5.29–8.28)

Median PV (IQR), ml

39.23 (30.03–61.36)

Median PSAD (IQR), ng/ml²

0.15 (0.11–0.25)

Median FPSA/TPSA (IQR)

0.15 (0.12–0.20)

Imaging characteristics

PI-RADS 1–2

27 (33.3%)

PI-RADS 3

23 (28.4%)

PI-RADS 4

16 (19.8%)

PI-RADS 5

15 (18.5%)

SUVmax

5.5 (3.5–8.3)

Pathological characteristics

Gleason score

0

44 (54.3%)

6

8 (9.9%)

7

22 (27.2%)

8

4 (4.9%)

9

3 (3.7%)

10

0 (0)

Gleason group

0

44 (54.3%)

1

8 (9.9%)

2

17 (21.0%)

3

2 (2.5%)

4

4 (4.9%)

5

3 (3.7%)